Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Response Genetics second quarter total revenue increases 18.8% to $6.7 million

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results and business progress for the second quarter ended June 30, 2011.

8 Aug 2011

Kaan Medikal to distribute Saladax's My5-FU diagnostic test in Turkey

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Kaan Medikal will serve as the exclusive distributor of Saladax's My5-FU diagnostic test throughout the Turkish market.

8 Aug 2011

American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the second quarter and first half of 2011.

8 Aug 2011

Ovarian cancer gene discovered

A new study finds that around one woman in 70 is at risk of developing ovarian cancer, which claims more than 4,200 lives a year and this could be attributed to a faulty RAD15D gene. The gene raised the risk to one in 11.

8 Aug 2011

New insights into cancer-induced intussusceptive angiogenesis

Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.

8 Aug 2011

New finding about cell metabolism may have implications for neurodegenerative disorders

Cells are the building blocks of the human body. They are a focus of scientific study, because when things go wrong at the cellular and molecular level the consequences for human health are often significant.

8 Aug 2011

Students of FAU's new Charles E. Schmidt College of Medicine receive first white coats

The 64 students who make up the inaugural class of Florida Atlantic University's new Charles E. Schmidt College of Medicine will receive their first white coats at a ceremony today to symbolically confirm their commitment to the profession of medicine.

6 Aug 2011

Clinical trial to assess impact of dietary change in men with prostate cancer

Two researchers from Roswell Park Cancer Institute (RPCI) have opened a clinical trial that will assess the impact of dietary change to control prostate cancer.

6 Aug 2011

Idera second quarter net loss increases to $6.3 million

Idera Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-Like receptors (TLRs).

5 Aug 2011

Transvaginal nephrectomy could increase rate of living donors for kidney transplants

Kidney transplant from a living donor, besides of being the best option for young people and those affected by particular conditions, results in increased organ survival and solves in part the organ shortage afflicting Spain since the mid-90 despite the high rate of cadaveric donation.

5 Aug 2011

New strategies for successful donor adult stem cell transplants in blood cancer patients

Findings by UT Southwestern Medical Center researchers may suggest new strategies for successful donor adult stem cell transplants in patients with blood cancers such as leukemia, lymphoma and myeloma.

5 Aug 2011

YM BioSciences reports preclinical results of CYT387 in multiple myeloma

YM BioSciences Inc., today reported preclinical results for its JAK1/JAK2 inhibitor CYT387 in multiple myeloma (MM), published in the advance online edition of Leukemia on July 26, 2011.

5 Aug 2011

OncoGenex second quarter revenue increases to $1.9 million

OncoGenex Pharmaceuticals, Inc. today provided an update on current events and activities and announced its second quarter financial results.

5 Aug 2011

ArQule second quarter net loss increases to $10,804,000

ArQule, Inc. today announced its financial results for the second quarter of 2011.

4 Aug 2011

Safe Kids USA to host Youth Sports Safety Clinics

With many young school athletes working hard this month to prepare for fall sports, Safe Kids USA is hosting Youth Sports Safety Clinics across the country to educate parents and coaches on how to keep children safe and prevent sports injuries, including heat-related illnesses. Nearly 3/4 of U.S. households have at least one child who plays organized sports.

4 Aug 2011

Micromet second quarter total revenues increase to $7.1 million

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

NIA, ACRO collaborate to create disease site-specific radiation oncology practice guidelines

National Imaging Associates (NIA), a subsidiary of Magellan Health Services, and the American College of Radiation Oncology (ACRO), the professional medical society established for educational and scientific purposes to advance the science and practice of radiation oncology, today announced the signing of a collaborative agreement.

4 Aug 2011

ASCO's statement identifies specific measures to help eliminate cancer care disparities

To help address serious racial and economic disparities in cancer prevention, diagnosis, and treatment in the United States, the American Society of Clinical Oncology (ASCO) today released a policy statement that outlines specific provisions of 2010 Patient Protection and Affordable Care Act that have the potential to reduce these disparities.

4 Aug 2011

W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

Scientists at Thomas Jefferson University have been awarded a $1 million medical research grant from the W.M. Keck Foundation for an ambitious project looking at the little explored 98 percent of the human genome and what role it may play in the onset and progression of diseases.

4 Aug 2011

Urine test for prostate cancer: Study

Lead researcher Dr. Scott Tomlins, a pathology resident at the University of Michigan Health System said, “This is a tool that men and their physician can use to help them decide whether it's appropriate to get a biopsy now or delay that decision.”

4 Aug 2011

Oncology News and Research

Further Reading

Response Genetics second quarter total revenue increases 18.8% to $6.7 million

Kaan Medikal to distribute Saladax's My5-FU diagnostic test in Turkey

American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

Ovarian cancer gene discovered

New insights into cancer-induced intussusceptive angiogenesis

New finding about cell metabolism may have implications for neurodegenerative disorders

Students of FAU's new Charles E. Schmidt College of Medicine receive first white coats

Clinical trial to assess impact of dietary change in men with prostate cancer

Idera second quarter net loss increases to $6.3 million

Transvaginal nephrectomy could increase rate of living donors for kidney transplants

New strategies for successful donor adult stem cell transplants in blood cancer patients

YM BioSciences reports preclinical results of CYT387 in multiple myeloma

OncoGenex second quarter revenue increases to $1.9 million

ArQule second quarter net loss increases to $10,804,000

Safe Kids USA to host Youth Sports Safety Clinics

Micromet second quarter total revenues increase to $7.1 million

NIA, ACRO collaborate to create disease site-specific radiation oncology practice guidelines

ASCO's statement identifies specific measures to help eliminate cancer care disparities

W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

Urine test for prostate cancer: Study

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News